Approval · Notice of Compliance 22278 · 2019
ZONOVATE: Notice of Compliance 22278
Issued June 12, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22278
- Date
- June 12, 2019
- Company
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZONOVATE | Not yet assigned | — |
Medicinal ingredients
- TUROCTOCOG ALFA 250 UNIT per VIAL
- TUROCTOCOG ALFA 500 UNIT per VIAL
- TUROCTOCOG ALFA 1,000 UNIT per VIAL
- TUROCTOCOG ALFA 1,500 UNIT per VIAL
- TUROCTOCOG ALFA 2,000 UNIT per VIAL
- TUROCTOCOG ALFA 3,000 UNIT per VIAL